Farshid Guilak, PhD, the Mildred B. Simon Research Professor of Orthopaedic Surgery and co-director of the Washington University Center of Regenerative Medicine, has received the 2021 Elizabeth Winston Lanier Kappa Delta Award for his research involving the treatment of arthritic joints, growing cartilage from patients’ donor cells and seeding them on a scaffold to create a living joint replacement as a treatment for hip arthritis.
Guilak and his collaborators spent more than 15 years developing the technology. He and co-investigators Bradley T. Estes, PhD, and Franklin T. Moutos, PhD, formed a startup company called Cytex Therapeutics that is advancing the technology.
The Kappa Delta Award recognizes research in musculoskeletal disease or injury that has great potential to advance patient care. The American Academy of Orthopaedic Surgeons presents three different Kappa Delta Awards annually, and Guilak has won all three. In 1998, he received the Kappa Delta Young Investigator Award for work with the biomechanics of cartilage. In 2015, he was part of a team that received the Kappa Delta Ann Doner Vaugh Award for work on preventing post-traumatic arthritis following fractures.
Guilak also is director of research at Shriners Hospitals for Children — St. Louis.